Towards Healthcare Research & Consulting
US Pharmacy Benefit Management Market
Updated Date: 09 October 2026   |   Report Code: 7087
[email protected] +1 804-441-9344
Download Sample Order Now

US Pharmacy Benefit Management Market Size, Trends & Forecast 2035

The U.S. Pharmacy Benefit Management Market is predicted to reach USD 1113.47 billion in 2035, over the forecast period. This growth is driven by rising specialty drug utilization, increasing prescription costs, GLP 1 adoption, and growing demand for pharmacy cost management. This report benefits several stakeholders, including pharmacy benefit managers, health insurance companies, pharmaceutical manufacturers, specialty pharmacies, retail pharmacies, large employers, healthcare consultants, and technology providers. 

Last Updated : 09 October 2026 Category: Pharmaceuticals Insight Code: 7087 Format: PDF / PPT / Excel

Content

Chapter 1: Introduction

  • Market Definition & Taxonomy
  • Research Objectives
  • Market Scope & Assumptions
  • Study Timeline (Historical, Base Year, Forecast Period)
  • Key Stakeholders Covered

Chapter 2: Research Methodology

  • Research Framework Overview
  • Market Size Estimation Methodology
    • Bottom-Up Approach
    • Top-Down Approach
  • Forecasting Model
    • Dependent Variables
    • Independent Variables
    • Key Assumptions & Weightages
  • Primary Research Insights
  • Secondary Data Sources
  • Data Validation & Triangulation

Chapter 3: Executive Summary

  • Global & Regional Overview (Value, CAGR)
  • Epidemiology Snapshot
  • Segmental Overview
  • Competition Key Snippets
  • Strategic Takeaways

Chapter 4: Market Catalysts, Constraints & Growth Levers

Market Dynamics

  • Market Drivers/Catalysts
    • Driver 1
    • Driver 2
  • Market Restraints
    • Restraint 1
    • Restraint 2
  • Market Opportunities
    • Opportunity 1
    • Opportunity 2
  • Market Trends
    • Trend 1
    • Trend 2
  • Impact Assessment of Drivers, Restraints, Opportunities & Trends (High, Mid, & Low)

Chapter 5: Value Added Intelligence

  • Porter’s Five Forces Analysis
    • Bargaining Power of Suppliers: Low/Moderate/High
    • Bargaining Power of Buyers: Low/Moderate/High
    • Threat of New Entrants: Low/Moderate/High
    • Threat of Substitute: Low/Moderate/High
    • Competitive Rivalry: Low/Moderate/High
  • PESTEL Analysis
  • Ecosystem Analysis
  • Mapping of Key Players
  • Value Chain Analysis
  • Margin Analysis Across Value Chain
  • Macro & Micro Factors Impacting Market
  • Market Potential Evaluation, By Region
  • Epidemiology & Patient Pool Analysis
    • Disease Incidence & Prevalence
    • Target Patient Pool
      • Diagnosed Population
      • Service-Seeking Population
    • Patient Flow & Utilization Analysis
      • Patient Footfall
      • Admission Rates
      • Procedure Volume
    • Healthcare Infrastructure Analysis
      • Number of Facilities
        • Hospitals
        • Clinics
        • Diagnostic Centers
        • ASCs
      • Bed Capacity
        • Total Beds
        • ICU Beds
      • Facility Distribution
    • Operational Metrics Analysis
      • Bed Occupancy Rate (%)
      • Average Length of Stay (ALOS)
    • Service Pricing & Revenue Model
      • Pricing Analysis
        • Cost per Procedure
        • Cost per Consultation
        • Cost per Diagnostic Test
      • Revenue Streams
        • Inpatient Services
        • Outpatient Services
        • Ancillary Services
      • Workforce & Staffing Analysis
        • Healthcare Workforce
          • Physicians
          • Nurses
          • Technicians
        • Staff-to-Patient Ratios
        • Skill Gap Analysis
        • Labor Cost Structure
      • Scenario Analysis (Base / Optimistic / Pessimistic)
      • Risk Assessment & Sensitivity Analysis
      • Opportunity Analysis, By Region
      • Regulatory Analysis
      • Sustainability & ESG Insights
      • Business Models
      • Investment & Funding Landscape
      • Key Conferences and Events

Chapter 6: Segmental & Regional Analysis

  • US Pharmacy Benefit Management Market Analysis, By PBM Service Type
    • Market Size, Forecast & CAGR, By PBM Service Type, 2022-2035
    • Key Rationale
    • Y-o-Y Analysis
  • US Pharmacy Benefit Management Market Analysis, By Payer Type
    • Market Size, Forecast & CAGR, By PBM Service Type, 2022-2035
    • Key Rationale
    • Y-o-Y Analysis
  • US Pharmacy Benefit Management Market Analysis, By Prescription Type
    • Market Size, Forecast & CAGR, By PBM Service Type, 2022-2035
    • Key Rationale
    • Y-o-Y Analysis
  • US Pharmacy Benefit Management Market Analysis,By Pharmacy Channel
    • Market Size, Forecast & CAGR, By PBM Service Type, 2022-2035
    • Key Rationale
    • Y-o-Y Analysis
  • US Pharmacy Benefit Management Market Analysis, By Customer Type
    • Market Size, Forecast & CAGR, By PBM Service Type, 2022-2035
    • Key Rationale
    • Y-o-Y Analysis
  • US Pharmacy Benefit Management Market Analysis, By PBM Business Model
    • Market Size, Forecast & CAGR, By PBM Service Type, 2022-2035
    • Key Rationale
    • Y-o-Y Analysis
  • US Pharmacy Benefit Management Market Analysis, By Revenue Model
    • Market Size, Forecast & CAGR, By PBM Service Type, 2022-2035
    • Key Rationale
    • Y-o-Y Analysis
  • US Pharmacy Benefit Management Market Analysis, By Specialty Pharmacy Category
    • Market Size, Forecast & CAGR, By PBM Service Type, 2022-2035
    • Key Rationale
    • Y-o-Y Analysis
  • US Pharmacy Benefit Management Market Analysis, By Therapeutic Area
    • Market Size, Forecast & CAGR, By PBM Service Type, 2022-2035
    • Key Rationale
    • Y-o-Y Analysis
  • US Pharmacy Benefit Management Market Analysis, By Technology
    • Market Size, Forecast & CAGR, By PBM Service Type, 2022-2035
    • Key Rationale
    • Y-o-Y Analysis
  • US Pharmacy Benefit Management Market Analysis, By Market Structure
    • Market Size, Forecast & CAGR, By PBM Service Type, 2022-2035
    • Key Rationale
    • Y-o-Y Analysis
  • US Pharmacy Benefit Management Market Analysis, By Customer Engagement Channel
    • Market Size, Forecast & CAGR, By PBM Service Type, 2022-2035
    • Key Rationale
    • Y-o-Y Analysis

Chapter 7: Competitive Insights

Competitive Analysis

    • Company Evaluation Matrix
      • Major Players
      • Mid-Sized Companies
      • Emerging Players/Start-Ups
    • Global Market Share Analysis, By Region, 2025 (%)
    • Key Player Positioning
    • Competitive Benchmarking
      • By PBM Service Type
      • By Payer Type
      • By Prescription Type
      • By Pharmacy Channel
      • By Customer Type
      • By PBM Business Model
      • By Revenue Model
      • By Specialty Pharmacy Category
      • By Therapeutic Area
      • By Technology
      • By Market Structure
      • By Customer Engagement Channel
    • Strategies of Key Players
    • Insight From the Horse’s Mouth

Company Profiles

    • Company 1
      • Company Name
      • Company Headquarters
      • Management Overview
        • Key C-Suite Executives
          • CEO
          • MD
          • Others
        • Employee Count
        • Business Strategy
          • Key Investments Made
          • Future Plans
          • R&D & Innovation Capabilities
          • Recent Developments
            • New Product Launch
            • Merger & Acquisitions
            • Partnerships & Collaborations
            • Market Expansion
            • Others
          • Service Portfolio
          • Facility Network
            • Number of Facilities
            • Bed Capacity
            • Facility Distribution
            • Expansion Pipeline
          • Key Financials (2022-2025)
            • Revenue By Segment
            • Revenue By Service
            • Revenue By Geography
            • Financial Matrix (Gross Profit Margins, Net Margins, etc.)
          • Key Clients
            • Client Company Name
            • Key Contact Person
            • Contact Details
          • Regulatory & Certification Expertise
          • SWOT Analysis

FAQ's

Answer : The U.S. Pharmacy Benefit Management market is projected to reach USD 1113.47 billion by 2035, based on the forecast framework for 2026-2035.

Answer : Major growth drivers include rising specialty-drug spending, increasing use of GLP-1 therapies, biosimilar adoption, growing prescription costs, demand for pharmacy cost management, real-time benefit management, and increased use of technology and analytics.

Answer : Growing GLP-1 utilization is increasing pharmacy spending and creating additional demand for formulary management, utilization controls, benefit design, prior authorization, and cost-management programs.
Any Questions

Meet the Team

Payal Rabde is a Healthcare Market Research Analyst at Towards Healthcare Research & Consulting with 4+ years of experience in pharmaceuticals, biotechnology, medical devices, and life sciences.

Learn more about Payal Rabde

Aditi Shivarkar is a seasoned professional with over 14 years of experience in healthcare market research. As a content reviewer, Aditi ensures the quality and accuracy of all market insights and data presented by the research team.

Learn more about Aditi Shivarkar